Multiple pre- and postreceptor defects in pseudohypoparathyroidism (a multicenter study with twenty four patients)

Area of Science:

• Endocrinology
• Genetics
• Biochemistry

Background:

• Hereditary pseudohypoparathyroidism (PsHP) is a rare genetic disorder characterized by resistance to parathyroid hormone (PTH).
• Pathophysiological mechanisms are complex, involving prereceptor defects, impaired G-protein signaling, or cytosolic response abnormalities.
• Understanding these mechanisms is crucial for accurate diagnosis and management.

Purpose of the Study:

• To differentiate pathophysiological mechanisms in hereditary pseudohypoparathyroidism.
• To identify distinct subpopulations of PsHP patients based on clinical and biochemical markers.
• To investigate the roles of PTH metabolites, vitamin D, and N-protein activity in PsHP.

Main Methods:

• Studied 24 patients with PsHP and 36 healthy children.
• Measured serum levels of various PTH fragments (N-PTH, mid-C-PTH, intact PTH, bio-PTH), vitamin D metabolites (25-hydroxyvitamin D, 1,25-dihydroxyvitamin D), calcium, phosphate, and alkaline phosphatase.
• Assessed N-protein activity in erythrocyte membranes and urinary cAMP excretion after PTH administration.

Main Results:

• Identified three patient groups: AHO+ with elevated N-PTH/mid-C-PTH, AHO+ with elevated bio-PTH/N-PTH/mid-C-PTH and decreased N-protein activity, and AHO- with normal PTH/N-protein but altered vitamin D metabolite levels.
• Group a showed dissociation of N-PTH and bio-PTH, suggesting renal PTH resistance.
• Group b exhibited generalized PTH resistance due to defective N-protein.
• Group c displayed high 25-hydroxyvitamin D and low 1,25-dihydroxyvitamin D, indicating cytosolic interaction defects.

Conclusions:

• Three distinct pathophysiological subtypes of PsHP were identified.
• Subtype 1 (Group a) involves defective N-PTH leading to renal resistance.
• Subtype 2 (Group b) is characterized by defective N-protein causing generalized PTH resistance.
• Subtype 3 (Group c) suggests a cytosolic defect in second messenger interaction, linked to vitamin D metabolism.